ANNETTE TAYLOR: Open Payments
NPI 1043753254 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 23 payments from 10 companies in 2025. Trend: 2023 $302 · 2024 $278 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| ABBVIE INC. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $42 |
| Novo Nordisk Inc | 2 | $38 |
| Gilead Sciences, Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $14 |
Products named: Auvelity, CAPLYTA, VRAYLAR, REXULTI, Cologuard Collection Kit, INGREZZA, Ozempic, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
